Seminars in Neurology

LinksSchließen

Referenz

Ponseti JM, Azem J, Fort JM, Codina A, Montoro JB, Armengol M.
Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study.

Clin Neurol Neurosurg 2005;
107 (3) 187-190

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: